Octreotide LAR in the Induction of Immunologic Response in NENs Patients

Summary

Evaluating the impact of OCTREOTIDE LAR on the immune response by studying Regulatory T-cell (T-Reg) and Myeloid-derived suppressor cells (MDSC) and the immunoregulatory cell population in peripheral blood of NET G1 / G2 patients treated with Octreotide LAR

Timeline

Start

2017-06-28

Primary completion

2019-12-01

Completion

2019-12-01

Drugs

Indications